1. Ambiguous Role of SATB1 Expression in Malignant Tumors
   Maciej Gagat et al, 2019, Journal of Investigative Dermatology CrossRef
2. Gene Expression Comparison between Sézary Syndrome and Lymphocytic-Variant Hypereosinophilic Syndrome Refines Biomarkers for Sézary Syndrome
   Andrea Moerman-Herzog et al, 2020, Cells CrossRef
3. SATB1 in Malignant T Cells
   Simon Fredholm et al, 2018, Journal of Investigative Dermatology CrossRef
4. Methyltransferase inhibitors restore SATB1 protective activity against cutaneous T cell lymphoma in mice
   Carly M. Harro et al, 2021, Journal of Clinical Investigation CrossRef
5. Adaptive and non-adaptive gene expression responses in prostate cancer during androgen deprivation
   Reetta Nätkin et al, 2023, PLOS ONE CrossRef
6. Differential SATB1 Expression Reveals Heterogeneity of Cutaneous T-Cell Lymphoma
   Yumei Gao et al, 2021, Journal of Investigative Dermatology CrossRef
7. Epigenetics in the Pathogenesis and Treatment of Cutaneous T-Cell Lymphoma
   Ping Zhang et al, 2021, Frontiers in Oncology CrossRef
8. The Special AT-rich Sequence Binding Protein 1 (SATB1) and its role in solid tumors
   Anja Frömberg et al, 2018, Cancer Letters CrossRef
9. The Thioredoxin-Interacting Protein TXNIP Is a Putative Tumour Suppressor in Cutaneous T-Cell Lymphoma
   Veronica Stolearenco et al, 2021, Dermatology CrossRef
10. Sézary syndrome originates from heavily mutated hematopoietic progenitors
    Carly M. Harro et al, 2023, Blood Advances CrossRef
11. Low SATB1 Expression Promotes IL-5 and IL-9 Expression in Sézary Syndrome
    Alberto Herrera et al, 2020, Journal of Investigative Dermatology CrossRef
12. TOX, TWIST1, STAT4, and SATB1 protein expressions in early‐stage mycosis fungoides
    Sinem Örnek et al, 2024, Journal of Cutaneous Pathology CrossRef